- Finisar Corporation FNSR shares dropped 19.4 percent to $28.12 after the company reported weaker-than-expected results for its third quarter and issued disappointing forecast for the current quarter.
- Ocera Therapeutics Inc OCRX shares tumbled 19.1 percent to $1.53. Ocera Therapeutics reported a Q4 loss of $0.22 per share.
- Inseego Corp INSG dropped 19 percent to $2.31. Inseego posted a wider-than-expected quarterly loss.
- Mueller Industries, Inc. MLI shares fell 18.3 percent to $31.78.
- TearLab Corp TEAR shares declined 17.6 percent to $3.88. Tearlab reported a Q4 loss of $0.81 per share on revenue of $7.121 million. The company also disclosed that it has begun process to explore strategic alternatives.
- Zumiez Inc. ZUMZ tumbled 13.2 percent to $18.23. Zumiez posted upbeat results for its fourth quarter. However, the company issued a downbeat guidance for the current quarter.
- CECO Environmental Corp. CECE dropped 13.3 percent to $10.19. CECO Environmental reported Q4 adjusted earnings of $0.35 per share on revenue of $100 million.
- Smith Micro Software, Inc. SMSI fell 12.9 percent to $1.18 on downbeat quarterly results.
- Second Sight Medical Products Inc EYES shares declined 12.3 percent to $1.36. Second Sight reported a Q4 adjusted loss of $0.17 per share.
- MeetMe Inc MEET dropped 11.2 percent to $5.16. MeetMe reported an offering of common shares.
- Ionis Pharmaceuticals Inc IONS shares dipped 10.4 percent to $41.02. Goldman Sachs downgraded Ionis Pharmaceuticals from Neutral to Sell.
- Sears Hometown and Outlet Stores Inc SHOS dropped 9.6 percent to $3.30. Sears Hometown reported a Q4 loss of $45.8 million.
- Surgery Partners Inc SGRY declined 8.7 percent to $19.12 after the company posted weaker-than-expected quarterly profit.
- Alexandria Real Estate Equities Inc ARE fell 4.2 percent to $108.98. Alexandria Real Estate Equities priced public offering of 6.1 million shares of common stock at $108.55 per share.
- Cara Therapeutics Inc CARA fell 3.7 percent to $16.85 after the company reported a wider-than-expected quarterly loss.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
